Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA

This publication has 30 references indexed in Scilit:

• Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum
  Neuroscience, 1993
• Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• Therapeutic Applications of Oligonucleotides
  Annual Review of Pharmacology and Toxicology, 1992
• Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum
  Developmental Brain Research, 1991
• Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine
  Neuropharmacology, 1991
• Molecular biology of the dopamine receptors
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• D ₁ and D ₂ Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
  Science, 1990
• Motor Response Following Repeated Apomorphine Administration is Reduced in Parkinsonʼs Disease
  Clinical Neuropharmacology, 1989
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
  Synapse, 1987
• Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral Supersensitivity
  Science, 1977